28 related articles for article (PubMed ID: 8658707)
1. In vitro and in vivo immune assessments of genetically-engineered pig skin grafts in New World (squirrel) monkeys.
Hara H; Foote JB; Hansen-Estruch C; Bikhet MH; Nguyen HQ; Javed M; Oscherwitz M; Collins DE; Ayares D; Yamamoto T; King TW; Cooper DKC
Xenotransplantation; 2023; 30(6):e12832. PubMed ID: 37870485
[TBL] [Abstract][Full Text] [Related]
2. Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival.
Mastroianni M; Ng ZY; Goyal R; Mallard C; Farkash EA; Leonard DA; Albritton A; Shanmugarajah K; Kurtz JM; Sachs DH; Macri LK; Kohn J; Cetrulo CL
J Burn Care Res; 2018 Apr; 39(3):363-373. PubMed ID: 28639977
[TBL] [Abstract][Full Text] [Related]
3. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs.
Misseghers BS; Binnington AG; Mathews KA
Can Vet J; 2000 Aug; 41(8):623-7. PubMed ID: 10945128
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
5. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
6. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
Masri MA
Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
[No Abstract] [Full Text] [Related]
7. Prolongation of xenograft survival by combining donor-specific intravenous presensitization with FK 506.
Iwata H; Umeda Y; Matsuno Y; Yoshikawa S; Marui T; Miyauchi T; Takagi H; Mori Y; Hirose H
Transplant Proc; 2002 Nov; 34(7):2745-8. PubMed ID: 12431592
[No Abstract] [Full Text] [Related]
8. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
[TBL] [Abstract][Full Text] [Related]
9. Topical immunosuppression in skin grafting with FK 506 ointment.
Yuzawa K; Taniguchi H; Seino K; Otsuka M; Fukao K
Transplant Proc; 1996 Jun; 28(3):1387-9. PubMed ID: 8658707
[No Abstract] [Full Text] [Related]
10. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression with melengestrol.
Kountz SL; Wechter WJ
Transplant Proc; 1977 Jun; 9(2):1447-53. PubMed ID: 327640
[No Abstract] [Full Text] [Related]
12. [Prolongation of graft survival--clinical practice, specific immune suppression in experiments and photochemotherapy of the graft].
Meffert H; Gruner S; Sönnichsen N; von Baehr R
Dermatol Monatsschr; 1985; 171(5):290-302. PubMed ID: 3894077
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
